From Diagnosis to Drug Development

https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/b7/aa/13/b7aa1359-be55-54cb-aac4-5c940db0bb82/mza_9473527047321604804.jpg/600x600bb.jpg

Moving Medicine Forward

CTI Clinical Trials

34 episodes

1 week ago

CTI Clinical Trial and Consulting Services presents Moving Medicine Forward, a podcast centered on advancements in healthcare and elevating individual’s stories and expertise. CTI, a global Contract Research organization with associates in 60 countries, has contributed to 10,000+ projects, 200+ drug and device approvals, and 300+ pharmaceutical and emerging biotechnology partners. Our group of innovative thinkers work to change the lives of chronically and critically ill patients.

Life Sciences

Science

RSS

All content for Moving Medicine Forward is the property of CTI Clinical Trials and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/39400744/39400744-1760642410602-4d2e0e8af564.jpg

From Diagnosis to Drug Development

Moving Medicine Forward

17 minutes 1 second

1 month ago

From Diagnosis to Drug Development

Chuck Scheper, Board Chair at Bexion Pharmaceuticals, shares how a stage IV non-Hodgkin lymphoma diagnosis at age 39 and a life-saving clinical trial led to his lifelong commitment to cancer research. He joins Tim Schroeder, CEO and Chairman of CTI, to discuss the founding of VaxCella, the evolution of cancer therapies, the importance of patient-centered research, and the role of collaboration in advancing drug development, highlighting resilience, innovation, and the impact of clinical trials.